[DISCLOSURE] Anterogen (065660) has obtained a Chinese patent for autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas, it announced on July 13.
Anterogen obtains Chinese patent related to clinical stem cell production
Published : July 13, 2016 - 15:37:38
